Interleukins in Cancer Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interleukins in Cancer Therapy

Published:1994-04 Issue:4 Volume:1 Page:271-281
ISSN:1172-7039
Container-title:Clinical Immunotherapeutics
language:en
Short-container-title:Clin. Immunother.

Author:

Oleksowicz Leslie,Sparano Joseph,O’Boyle Kevin,Venkatraj Usha,Wiernik Peter H.,Dutcher Janice P.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/BF03259253.pdf

Reference80 articles.

1. Mule JJ, Shu S, Schwartz SL, et al. Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Science 1984; 225: 1487–9

2. Whittington R, Faulds D. Interleukin-2: a review of its pharmacological properties and therapeutic use in patients with cancer. Drugs 1993; 46: 446–514

3. Rosenberg SA, Lotze MT, Muul LM, et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985; 313: 1485–92

4. Rosenberg SA, Lotze MT, Muul LM, et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 1987; 316: 889–97

5. Fisher RI, Coltman CA, Doroshow JH, et al. Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. Ann Int Med 1988; 108: 518–23

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of histology on the treatment outcome of metastatic or recurrent renal cell carcinoma;Medical Oncology;1998-04

2. Immunomodulating Effect of Blood Transfusion: Is Storage Time Important?;Vox Sanguinis;1998-04

3. Conditioning Regimens in Autologous Bone Marrow Transplantation;Clinical Immunotherapeutics;1994-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3